Documents and quality

Match each document to its purpose

Initial technical information supports screening. Actual supply requires the documents approved for the selected specification and batch.

DocumentCurrent purposeNext step
Candidate briefsExisting initial-review informationChoose a source below
Technical-evaluation TDSInitial technical review, not released commercial limitsRequest the relevant version
SDS and actual-batch COAApproved safety and batch documents required before supplyConfirm with QA for the selected specification and lot
Storage and transport instructionsApproved conditions for the actual shipmentConfirm evidence, packaging and destination route before dispatch

Portfolio overview · Existing evaluation-path PDF

Company quality-system certificate

View the existing ISO 9001 certificate

The certificate states validity through 1 June 2029, subject to surveillance. Its technical-R&D scope is not ISO 22716, a product approval, an efficacy result or a sterile-product release claim.

INCI naming

INCI naming applications have been submitted. Results are expected in late November 2026, subject to review; neither the date nor the outcome is guaranteed. Naming does not establish ingredient safety or destination-market authorization.

Evidence boundaries

Particle counts and size do not alone establish EV purity or activity. Existing multi-ingredient finished-product reports cannot be treated as raw-material compatibility, stability or efficacy results. Initial review is non-clinical formulation evaluation, not testing on people. These preparations are not offered for injection or therapeutic use.

Discuss the documents you need